The One to Beat | GenomeWeb

The One to Beat

Matthew Herper at Forbes lays the credit for the growth of Illumina and next-generation sequencing at the feet of Jay Flatley, the company's chief executive officer. Since 2008, under Flatley's guidance, Illumina's sales have increased nearly 150 percent to $1.42 billion, Herper says, while its stock has shot up some 617 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.